Cardiac troponin levels play a crucial role in the diagnosis and assessment of heart-related conditions. Troponins are proteins found in cardiac muscle cells, and their release into the bloodstream is a reliable indicator of myocardial injury, such as a heart attack. When heart muscle is damaged, whether due to reduced blood flow or other cardiac events, troponin is released, and its levels in the blood rise. Therefore, measuring cardiac troponin levels is a key diagnostic tool for healthcare professionals in identifying and confirming acute myocardial infarction. High sensitivity troponin assays have enhanced the precision of detecting even minor cardiac injuries, allowing for early intervention and improved patient outcomes. Monitoring troponin levels over time can also aid in assessing the extent of heart damage and guiding ongoing treatment strategies. As an integral component of contemporary cardiac care, the measurement of cardiac troponin levels has significantly contributed to advancing the field of cardiology and improving patient care.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain